Many modern cancer treatments, including immunotherapy, depend on activating killer T cells to recognise and destroy tumours.

The study is structured to assess the anti-tumour efficacy, biomarker effects, recommended dose, safety and tolerability of ...

N17350 is a tumor-directed therapeutic elastase designed to selectively kill cancer cells, while preserving immune cells, and ...

Utah State University scientists recently unveiled a new type of CRISPR biotechnology with the ability to selectively target ...

Scientists have uncovered a surprising new way the immune system fights cancer, overturning a core belief that has guided ...

Natural killer cells are supposed to be the immune system’s first responders against cancer. They don’t need to be trained on ...

Researchers found that lowering MHC I can expose cancerous or foreign cells to CD4+ T cell attack, reshaping assumptions ...

Cancer cells have a survival trick that nobody expected: they co-opt vitamin B2, one of the most ordinary nutrients in the ...

Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of current therapies ...

A team of researchers at The University of Texas at Austin and the University of Porto have created a new way to target cancer—tin-based nanomaterials combined with near-infrared light. Their work has ...

Mountain climbers and endurance athletes are not the only ones to benefit from altitude training - that is, learning to perform well under low-oxygen conditions. It turns out that cancer-fighting ...